Live vectors: are safe but effective vaccines possible?

Affiliations

Comment

Kingston H G Mills. Drug Discov Today. 2002.

. 2002 Aug 15;7(16):854-5.

doi: 10.1016/s1359-6446(02)02365-6.

¹ Immune Regulation Research Group, Dept of Biochemistry, Trinity College, Dublin 2, Ireland.

No abstract available

Comment on

Virus-based vectors for human vaccine applications.
Polo JM, Dubensky TW Jr. Polo JM, et al. Drug Discov Today. 2002 Jul 1;7(13):719-27. doi: 10.1016/s1359-6446(02)02324-3. Drug Discov Today. 2002. PMID: 12110228 Review.

Heterologous prime-boost immunization of Newcastle disease virus vectored vaccines protected broiler chickens against highly pathogenic avian influenza and Newcastle disease viruses.
Kim SH, Samal SK. Kim SH, et al. Vaccine. 2017 Jul 24;35(33):4133-4139. doi: 10.1016/j.vaccine.2017.06.055. Epub 2017 Jun 28. Vaccine. 2017. PMID: 28668574
Live and killed rhabdovirus-based vectors as potential hepatitis C vaccines.
Siler CA, McGettigan JP, Dietzschold B, Herrine SK, Dubuisson J, Pomerantz RJ, Schnell MJ. Siler CA, et al. Virology. 2002 Jan 5;292(1):24-34. doi: 10.1006/viro.2001.1212. Virology. 2002. PMID: 11878905
Where are we now with vaccines against AIDS?
Schild GC, Stott EJ. Schild GC, et al. BMJ. 1993 Apr 10;306(6883):947-8. doi: 10.1136/bmj.306.6883.947. BMJ. 1993. PMID: 8490466 Free PMC article.
Why treat? Better prevent: adult immunization.
Kishore PV, Palaian S, Paudel R, Paudel B, Mishra P, Prabhu M. Kishore PV, et al. Kathmandu Univ Med J (KUMJ). 2008 Jan-Mar;6(1):122-7. Kathmandu Univ Med J (KUMJ). 2008. PMID: 18604129 Review.
Feasible improvements in vaccines in the Expanded Programme on Immunization.
McIntosh K. McIntosh K. Rev Infect Dis. 1989 May-Jun;11 Suppl 3:S530-7. doi: 10.1093/clinids/11.supplement_3.s530. Rev Infect Dis. 1989. PMID: 2669097 Review.